MannKind Shares Rise After Selling Royalty Interest in Tyvaso DPI
In a major financial move, MannKind, a drugmaker, has sold part of its royalty interest in Tyvaso DPI for...
MannKind
MannKind Sells 1% Royalty Interest in Tyvaso DPI Sales for Up to $200 Million
MannKind, a biopharmaceutical company, has sold a 1% royalty interest in sales of the lung-disease treatment Tyvaso DPI to...
MannKind and Amphastar Modify Supply Agreement
In a regulatory filing, MannKind and Amphastar Pharmaceuticals have announced a revision to their supply agreement, allowing for a...